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The preparation of biological samples for electron microscopy is material- and 
time-consuming because it is often based on long protocols that also may 
produce artifacts. Protein labeling for transmission electron microscopy (TEM) is 
such an example, taking several days. However, for protein-based 
nanotechnology, high resolution imaging techniques are unique and crucial tools 
for studying the spatial distribution of these molecules, either alone or as 
components of biomaterials. In this paper, we tested 2 new short methods of 
immunolocalization for TEM, and compared them with a standard protocol in 
qualitative and quantitative approaches by using four protein-based 
nanoparticles. We reported a significant increase of labeling per area of 
nanoparticle in both new methodologies (H=19.811; p<0.001) with all the model 
antigens tested: GFP (H=22.115; p<0.001), MMP-2 (H=19.579; p<0.001), MMP-
9 (H=7.567; p<0.023), and IFN-  (H=62.110; p<0.001). We also found that the 
most suitable protocol for labeling depends on the nanoparticle’s tendency to 
aggregate. Moreover, the shorter methods reduce artifacts, time (by 30 %), 
residues and reagents hindering, losing, or altering antigens, and obtaining a 
significant increase of protein localization (of about 200 %). Overall, this study 
makes a step forward in the development of optimized protocols for the nanoscale 
localization of peptides and proteins within new biomaterials. 
 





Nanotechnology has rapidly emerged as a powerful set of platforms with limitless 
potential to create new and highly specific solutions for several fields. These 
include the development of innovative therapies and new generation of drugs 
aimed to solve current limitations of the pharmaceutical industry. In 
nanomedicine, the development of nanocarriers for drug delivery opens the path 
to generate more effective and personalized treatments for important human and 
animal diseases [1-3]. In contrast with conventional drugs, the new generation of 
nanoscale drugs show improved stability, extended circulation time, reduced 
toxicity, high therapeutic efficacy, and cell targeting [4]. Specifically, natural and 
engineered peptides and proteins are among the most suitable building blocks 
for nanoparticle generation due to their full biocompatibility and degradability at 
physiological conditions and versatility to be engineered and produced in single 
step by inexpensive biological processes [1]. Moreover, protein-based materials 
can be tuned by modifying both production conditions and genetic cell 
background [5-8], to generate a wide spectrum of protein nanoparticles with 
different composition, structure, size, and shape adapted to specific uses in 
animal and human medicine [9-12]. During the last years, peptide- and protein 
based biomaterials have emerged as convenient nano- and micro- carriers fully 
compatible with cells, tissues, and entire organisms [13]. They have great loading 
capacity and a high efficiency in differential transport, biodistribution, and/or 
release compounds with therapeutic interest [1;14-17]. 
 
In the context of this drug delivery-oriented research, high resolution imaging is 
crucial for resolving the spatio-temporal distribution, for quantifying the amount of 
peptide or proteins building blocks, or for understanding their form at nanoscale 
level, and for predicting and studying their potential function in different complex 
biological systems. The large number of high resolution imaging devices coupled 
with a wide variety of detectors allows obtaining 2D or 3D images of a wide 
spectrum of liquid and solid samples. Then, common nanoscale imaging has 
been used to characterize surface roughness, geometry (size and shape), and 
ultrastructural details of liquid and solid nanobiomaterials at more or less native 
state by atomic force microscopy (AFM), tunnelling force microscopy (TFM), or 
near-field scanning optical microscopy (NSOM). Other types of scanning probe 
microscopy (SPM) are used to study surfaces [18], whereas a wide variety of 
techniques and devices are available for obtaining other information at high 
resolution imaging reaching until few nanometres resolution [19-21]. Electron 
microscopy (EM), apart from being used to study surfaces, is probably the most 
used set of imaging techniques to determine inner details of biomaterials [22]. In 
fact, EM methods are powerful techniques that allow the imaging of cells, 
organelles, macromolecules, and atoms until native state. At present, 
transmission electron microscopy (TEM) is probably one of the most used set of 
techniques to characterize nanobiomaterials, achieving a spatial resolution 
adequate to localize, quantify, and map specific peptides or proteins at nanoscale 
level. In this context, cryomethods are a group of techniques to process EM 
samples that substitute conventional chemical methods (fixatives, metal oxides, 
epoxy resins, etc) for physical methods (high pressure, low temperature), thus 
increasing resolution, decreasing artifacts, and also allowing the visualization of 
the ultrastructure at nearly native state and to localize molecules or elements at 
ultrastructural level that may be altered with conventional methods [23;24]. Post-
embedding immuno EM (iEM), probably the most common set of cryomethods 
for TEM, has been explored using different electrodense markers such as ferritin 
or peroxidase. However, colloidal gold beads of a determinate size range (from 
1 to about 40 nm) coupled to immunoglobulins or proteins such as protein A or 
G, are the most used secondary antibodies trackers to localize antigens at 
nanoscale [25-27]. Nevertheless, despite the progress in this field, there is still an 
important requirement related to the development of improved techniques or 
methods, to obtain high resolution imaging of different types of samples 
[23;25;28-32] in a fast and effective manner. Although some specific contributions 
have displayed a time-, material-saving and improved results [23;33-35]; the 
optimization of TEM methods is clearly not enough achieved, especially for 
biomaterials. In this context, pre- and post-embedding immunolabeling protocols 
for TEM are a key question to link biochemistry, molecular biology, structural and 
ultrastructural studies or other newer research techniques with the spatio-
temporal localization of peptides and proteins in a quantitative manner at 
nanoscale [24;25;35-37]. Here, we have developed two new post-embedding iEM 
methods for peptide and protein biomaterials based on the most used 
conventional approaches for TEM immunolabeling, aimed to the reduction of 
time, reagents, and steps of labeling, that would in turn reduce costs, residues, 
and artifacts and increase protein localization (then, method efficiency and 
efficacy) of less altered nanobiomaterials. For that, we have used protein-based 
nanoparticles, also known as protein aggregates, as biomaterials model to 
evaluate the potential of the above mentioned protocols. 
 
2. Material and methods 
 
2.1. Protein design 
The green fluorescent protein (GFP) and three proteins of bovine (Bos taurus sp.) 
origin, the catalytic domain of matrix metalloproteinase 2 (MMP-2; from Tyr110 
to Asp45 NM_174745) and 9 (MMP-9; from Phe107 to Pro449 NM_174744) and 
the mature form of the interferon gamma (IFN-; from Gln23 to Thr101 
NM_173925) were used, as described in [38]. All proteins were produced as 
protein-based nanoparticles (aggregated nanoparticles) in Lactococcus lactis 
NZ9000 clpP-htrA- (clpP-htrA; EmR) [38-40] (kindly provided by INRA, Jouy-en-
Josas, France; patent nº EP1141337B1) using pNZ8148 vector (MoBiTech).  
 
2.2. Nanoparticle production and purification 
The production of protein-based nanoparticles was induced by the addition of 
12.5 ng/ml nisin (Sigma-Aldrich) in bacterial cultures growing in M17 broth plus 
0.5 % glucose at 30 ºC without shaking for 3 h. Once produced, protein 
nanoparticles were purified under sterile conditions and all incubations were 
carried out under agitation, using the purification protocol described by [41], and 
by adding at the beginning a mechanical disruption step by French Press. 
 
2.3. Labeling and imaging 
To reduce time and artifacts, we shorted long steps or and simplified or eliminate 
the non-crucial steps for the antigenicity maintenance and protein localization. 
Schematic summary of the three methods is shown in Figure 1 and detailed in 
Figure S1. Samples of protein-based nanoparticles by GFP, MMP-2, MMP-9, 
and IFN- were processed: 
 
1- Standard Protocol (SP): fixation in 4 % (w/v) formaldehyde (TAAB) and 0.1 % 
(v/v) glutaraldehyde (Merck) in phosphate buffer (PB; Sigma-Aldrich) for 30 min 
and stored in 1 % (w/v) formaldehyde prepared in PB. Samples were rinsed in 
PB, placed during 1 h with 20 mM glycine (Sigma-Aldrich) to quench free 
aldehydes, rinsed in PB, cryoprotected in graded series of sucrose (2 h in 0.7, 2 
h in 1.4 and 12 h in 2.3 M; Sigma-Aldrich) solutions prepared in PB, and cryofixed 
in liquid propane in an EM CPC (Leica Microsystems). Vitrified samples were 
immersed in methanol (Merck) containing 0.5 % uranyl acetate (Polysciences 
Inc.) for 72 h at -90 ºC, washed with methanol for 3 h at -45 ºC, embedded in 
Lowicryl HM20 resin (Polysciences Inc.) for 24 h at -45 ºC, and polymerized with 
UV rays for 48 h at -45 ºC followed by 48 h at 25 ºC in an EM AFS automatic 
freeze substitution system (Leica Microsystems). 
 
2- New Simplified Protocol 1 (NSP1): Rapid cryoprotection with glycerol (10 % 1 
h, and 30 % 0.5 h, Sigma-Aldrich) solutions in PB without fixation with aldehydes, 
cryofixation in liquid propane and rapid cryodehydration (24 h in 0.5 % uranyl 
acetate at -90 ºC), rapid embedding (4 h) and same polymerization than SP. We 
eliminated steps of fixation and reduced cryoprotection and cryodehydration 
times, resulting in a reduction of about 25 % of time in relation to SP. 
 
3- New Simplified Protocol 2 (NSP2): Direct cryofixation in propane, rapid 
cryodehydration without uranyl acetate step, embedding and polymerization as 
NSP1. We eliminate fixation and cryoprotection steps and we reduced 
cryodehydration and embedding times, resulting in a reduction of about 40 % of 
time in relation to SP. 
 
Ultrathin sections (70 nm) of selected areas of semithin sections (1 µm) of each 
sample were obtained with Leica ultracut UC6 microtome (Leica Microsystems), 
placed on carbon-coated gold grids (200 mesh) and labeled in parallel for the 4 
antigens of interest [22;38;42]. Briefly, sections were blocked in 1 % (w/v) bovine 
serum albumin (BSA; Sigma-Aldrich) in phosphate buffered saline (BSA/PBS) 
containing 20 mM of glycine (Sigma-Aldrich), incubated with the respective 
primary polyclonal primary antibody anti-GFP (#ab6556, Abcam), anti-MMP-2 
(#AV20016, Sigma-Aldrich), anti-MMP-9 (#50560-RP01, Sino Biological Inc.), or 
anti-IFN- (#ab9657, Abcam) at working dilution 1:25, 1:5, 1:5 and 1:2 
respectively, washed in BSA/PBS, incubated in protein A coupled to 10 nm-gold 
particles (BBI Solutions) at working dilution 1:50, and washed firstly in PBS and 
then in deionized (MilliQ) water. Grids were contrasted with conventional uranyl 
acetate (15 min) and lead citrate (1 min), and examined with a TEM Jeol JEM-
1400 (Jeol Ltd.) operating at 80 kV and equipped with a CCD Gatan ES1000W 
Erlangshen camera. 
 
To imaging fluorescence at ultrastructural resolution, ultrathin sections of GFP 
samples in the same gold grids were observed without contrasting in a STEM 
mode in a Field Emission Scanning Electron Microscope (FESEM) Zeiss Merlin 
(Zeiss) operating at 2 kV. Images of morphology were obtained with a secondary 
electron (SE) detector and images of fluorescence were obtained with a back-
scattered electron (BSE) detector. GFP fluorescence measurements were 
obtained by calculating the mean gray value from out part of nanoparticles 
(background) to the internal using Image J software (NIH Image). 
 
2.4. Quantitative analyses 
For antibody labeling detection, 20 images at same magnification (15,000X), for 
each sample and method, were randomly collected from 10 ultrathin sections. 
Then, for each sample and method, 30 protein nanoparticles were selected for 
quantification. In each nanoparticle, gold particles were counted and area was 
determined by binarizing images. For fluorescence determination, mean gray 
value was measured. Quantitative values were obtained for each method of GFP; 
measuring 30 randomly distributed 20 nm squared point inside the nanoparticles, 
then subtracting the mean value of 5 measures of 20 nm squared point from the 
background. Both analyses were carried out with Image J software (NIH Image). 
 
2.5. Statistical analyses 
Quantitative data are expressed as mean ± standard error. Comparison of 
methods of all proteins and for each protein and of fluorescence quantifications 
methods of GFP was made with Kruskal-Wallis H tests. Pairwise comparisons of 
methods for each protein were made with Mann-Withney U tests. Significance 
was accepted at p<0.05 and Bonferroni correction was applied for sequential 
comparisons. All statistical analyses were performed with SPSS v. 18 for 
Windows. 
 
3. Results and Discussion 
 
3.1. Improving protocols of post-embedding immunolocalization 
Pre and post-embedding immunolocalization TEM techniques are a set of current 
experimental methods that allow the visualization of antigens and offer a high-
throughput manner to obtain high resolution images; however, they are material- 
and time-consuming processes. Some routine iEM cryomethods are a perfect 
example of this negative aspect. They have very long protocols, with steps taking 
from hours to days. One of the most common labeling techniques for TEM is the 
conventional protocol detailed in material and methods (SP) (Figure 2). It has 
been widely used to localize different peptides and proteins in a wide range of 
biological systems such as bacteria [43;44], fungi [42;45], plants [46;47], culture 
eukaryotic cells [22;48], or animals [49;50]. Short versions of these long protocols 
were described for a wide variety of biological samples [23;31;35;36]. On one 
hand, by shortening the protocol to drastically reduce the costs of specialized 
staff, expensive reagents and devices, and potential artifacts in samples due to 
delocalization, lost or alteration of antigens and other ultrastructural details of 
samples [24;37]. Moreover, reducing the handling time of technically complicated 
methods also reduces potential human errors and exposure to toxins. On the 
other hand, by preserving the native state of the samples it may also conserve 
antigenicity due to less altered peptides and proteins, getting a higher labeling in 
less artifacted nanomaterials that allows the obtaining of robust quantitative and 
qualitative data [24]. Recently, several biomaterials, nano- and micro-structures 
with drug delivery and antimicrobial interest have been characterized by 
localizing a wide variety of peptides or proteins [13;43;51;52]. However, no 
specific studies of these new materials have ameliorated imaging techniques for 
the localization of antigens at nanoscale level. In our knowledge, the present 
study is the first reference of improved TEM immunolabeling protocols in 
biomaterials and opens a way of improved high resolution imaging by focusing 
on protein based nanoparticles with therapeutic interest.  
 
3.2. Protein nanoparticles as biomaterial model 
In this study, we have implemented two new procedures of pre-embedding 
immunolocalization for TEM (Figure 1) by using complex protein nanoparticles 
as a biomaterial model. The principal aim of our work was to increase protein 
localization and to reduce the complexity of sample handling in the detection of 
protein in intracellular nanoparticles. From a qualitative point of view, there are 
no changes in the aspect and size of samples independently of the method used 
(Figure 2). However, protein nanoparticles were more electrodense when using 
the newly developed methods (Figure 2) that may be related to more conserved 
protein and, therefore, available for labeling. The study of this hypothesis, 
quantifying GFP fluorescence in the three methods in non-labeled ultrathin 
sections (Figure 3) revealed a clear pattern of GFP increases in nanoparticles 
when methods are shortened. Although more specific studies are needed with 
different antigens, we consider that the increase of electrodensity may be related 
with more protein being present in nanoparticles in shorter methods. This could 
be due to some protein being released from the biomaterials after the long and 
abundant steps of conventional labeling method. Finally, an unexpected 
advantage was found in the new protocols: a general reduction of cell debris 
around protein-based nanoparticles. Whereas in standard protocol, the 
nanoparticles of the four proteins were surrounded by non-labeled cell debris 
from bacterial cells; these residues were either reduced or disappeared in the 
new protocols (Figure 2). These results may be related to the non-fixation of 
samples that conserve protein deposits but not in the same manner as the rest 
of cellular components from the cell debris. 
 
3.3. Quantitative analyses of labelling and fluorescence 
The main result obtained in the present study is a significant increase of specific 
labeling with the new protocols compared with the standard protocol in all 
samples studied (H=19.811, p<0.001). For each protein, significant differences 
were observed all showing an increase of labeling in the new methods: at p<0.001 
level GFP (H=22.115), MMP-2 (H=19.579), and IFN- (H=62.110), and at level 
p<0.023 for MMP-9 (H=7.567). Pairwise comparisons also detected significant 
increases of labeling of new protocols in relation to standard protocol (Figure 
3C). Although all the proteins produced in this study are able to be self-assembled 
to form protein nanoparticles (aggregates) in bacterial cytoplasm, different 
proteins have different aggregation propensity. Specifically, it has previously 
been published that GFP and IFN- have lower tendency to aggregate (50.27 % 
and 3.07 %, respectively) than MMPs (MMP-2: 100 % and MMP-9: 99.27 %) in 
protein-based nanoparticles [38]. Along this line, two clearly different patterns 
were observed by type of protein. Proteins with lower tendency to aggregate 
(GFP and IFN-) had heaviest labeling in the shortest method (NSP2), 
meanwhile, proteins prone to aggregate (MMP-2 and MMP-9), are better 
detected in NSP1 (Figures 2 and 3C). The increase of labeling indicates a high 
amount of protein conserved in protein nanoparticles without alteration and with 
intact antigenicity to specific primary antibodies, as demonstrated by the increase 
of GFP fluorescence (Figures 3A and 3B). As recently described, the 
supramolecular organization of those nanoparticles consists of a fully resistant 
core in which protein with native or quasi native-like structure is embedded in 
[38]. This native protein has been described as it could be naturally released from 
nanoparticles under incubation in water-based salt solutions [5]. Therefore, in the 
case of biomaterials with lower tendency to aggregate (as much time they are in 
solution during the method), some proteins were lost or altered during the long 
steps in liquid and, consequently, there were less labeling. For this reason, in 
IFN- and GFP nanoparticles we observe more protein in the NSP2 in comparison 
with NSP1, because we have minimized the number of aqueous-based solutions 
(fixation, rinse, cryoprotection), thus reducing significantly the time in which 
nanoparticles may be rinsed and protein lost in solution. Nevertheless, in robust 
nanoparticles, such as the MMPs in which less protein release is observed, it is 
important to maintain the nanoparticle core, where most of the protein is found, 
more protected [5;38]. For MMPs, the conventional method maintains a high 
percentage of protein available for antibody detection. However, this 
immunolocalization significantly increases with NSP1 and NSP2 methods, 
although at lesser extent than for less aggregation-prone proteins. In relative 
terms, when using the news methods, there was a tendency towards the increase 
of labeling of about 200 % in the four antigens tested, with a dramatic increase 
(near 2,000 %) in the case of IFN-, which are the protein nanoparticle with less 
propensity to be formed. Overall, these results indicate that short methods are 
useful to label peptides and proteins at ultrastructural level, but experiments must 
be designed depending on the physico-chemical characteristics of the antigen as 
well as on the 2D or 3D presentations of such biomaterials. As a disadvantage, 
new methods without fixation may be limited to biomaterials without complex cell 
structure. As alternative, these protocols may be coupled to a first rapid step of 
cryofixation such as high pressure freezing. The reduction or elimination of the 
rest of steps may be, then, explored in virtually all types of samples as an 
interesting improvement of time and cost of TEM protocols. 
 
3.4. Advantages and disadvantages of new methods 
Although these appealing new methods present some artifacts related to ice 
crystal formation (in a few of fields), as described in Figure S2, more labeling and 
less impurities around protein nanoparticles are detected (Figure 2). The result 
may be explained because these common artifacts in cryomethods destroy the 
nanoarchitecture but not necessarily decrease the antigenicity in these 
suboptimal parts of the samples. In contrast, optimal cryofixation areas deal with 
the formation of vitreous or amorphous ice that cryoimmobilize sample 
components without morphometric or compositional alteration. Then, the newly 
proposed methods enhance the sensibility of the technique, increasing the 
protein maintained in the sample and/or increasing the percentage of unaltered 
protein and potentially exposed to antibodies for localization. Moreover, it is 
important to point out that no background was observed in any sample after step 
cut down. The implementation of these shorter protocols offers important 
advantages such as fewer steps, samples in a nearly native state, fewer devices 
used, manipulation and specialized staff, and the reduction of potential artifacts; 
in other words, a cost-effective research. Despite reducing protocols steps, we 
also obtained an increase of labeling with the new methods, demonstrating that 
is possible to adapt standard techniques to new challengers of imaging at 
nanoscale level. 
 
The labeling increase is a clear signal of technological improvement and may 
have a direct application in a wide spectrum of peptide and protein samples. From 
an economical point of view, only therapeutic peptides and proteins are a 
multibillion-dollar market with a strong growing prevision [53].They play a major 
role in the present and future perspectives of medicine with important 
contributions in the treatment of diseases such as cancer or as efficient 
antimicrobial agents. However, most nanotechnological products fail to become 
a commercially viable because of the lack of characterization, among other 
reasons [54]. So, rapid and cheap methods such as ours may be applied for the 
adequate characterization of complex molecules and their future 
commercialization. Although, in this study, we have evaluated the efficiency of 
the newly developed protocols with protein-based aggregates, the study of 
peptides and proteins in a wide plethora of presentations at nanoscale such as 
self-assembling nanoparticles [14;52;55-57], bioinspired proteosomes [58;59], 
dendrimers [60], micelles [61;62], scaffolds [63], nanocomposites [3], coiled-coils 
[64;65], and vault nanocapsules [66;67], among others [13;53;68], could be 
substantially improved with these two new approaches. Although more specific 
studies are necessary, the results presented here focused on the use of general 
methods as a first screening of samples but with the mind in specific protocols to 
obtain best possible localization of peptides and proteins in a wide variety of 
samples. 
 
4. Concluding remarks 
The improvement of imaging methods to localize protein monomers, alone or 
nanostructured in form of protein nanoparticles or aggregates, as well as 
combined with other organic or inorganic nanostructures, is crucial to understand 
their form at nanoscale level and their function in biological systems with different 
organization (from cell cultures to entire organisms). On the other hand, since EM 
techniques continue to be among the most used set of high resolution imaging 
due to the realistic and easily interpretable 2D and 3D images, high versatility of 
biological and material samples, and wide type of morphological and 
compositional information, the interest to improve high-resolution techniques is 
crucial to obtain the best for nanotechnology studies in general and 
nanobiomaterials in particular. 
 
The intensification of labeling obtained at nanoscale resolution together with a 
time and reagents reductions allows to improve the efficacy to map peptides and 
proteins at high resolution in virtually all types of nano- and micro-biomaterial 
presentations such as particles, scaffolds, dendrimers, vault capsules, and/or 
composites. With a general increase of labeling near 200 % and time reduction 
of method of 30 %, the methods presented explore a more efficient way of high 
resolution imaging of biotechnological and pharmaceutical relevant peptides and 
proteins for nanotechnology uses.  
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Figure 1: Schematic summary of the three methods presented in this study, 
detailing each step. Box widths represent time of step, and an approximate time 
of each step and entire protocol is also reported. 
 
Figure 2: Representative micrographs of TEM immunolocalization at three 
magnifications of the four protein antigens (GFP, MMP-2, MMP-9, IFN--) by 
using the three methods studied: Standard protocol (SP), New simplified protocol 
1 (NSP1) and New simplified protocol 2 (NSP2). Each protein nanoparticle was 
labeled with a specific antibody. Scale bars: left inset 200 nm; right inset 100 nm; 
lower micrographs 500 nm. 
 
Figure 3: Representative micrographs of (A) nanoparticles morphometry and 
GFP fluorescence in the three methods, by using back-scattered electron (BSE) 
detector to quantify fluorescence and using secondary electron (SE) detector as 
reference of morphological aspect (Scale bars: 100 nm), and quantifications of 
(B) fluorescence by antigen area and method  and (C) labeling regarding the 
three methods and four antigens tested: Standard protocol (SP), New simplified 
protocol 1 (NSP1) and New simplified protocol 2 (NSP2). The standard error is 
represented by either black or grey lines at each sample. Level of significant 
differences between three methods and each productive strains are indicated by 
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